InsiderClue
← All stocks

CORCEPT THERAPEUTICS INC

CORT Net selling
CIK 0001088856 #827 in the set updated 17 Sep 2026
Bought (12 mo)
$3.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$102.49M
$29.98M on a plan · $68.79M straight out of an exercise
Sold at will
$3.72M
5 of 108 sales
Net
−$99.17M
−$404.15K against sales at will

By person

14 insiders · 120 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Maduck Sean
See Remarks
—
$23.27M (20) scheduled
−$23.27M
53,938
0.0499%
$6.03M
+37.0%
Mokari Atabak
Chief Financial Officer
—
$18.73M (22) scheduled
−$18.73M
16,304
0.0151%
$1.82M
+30.2%
Guyer William
Chief Development Officer
—
$14.91M (19) scheduled
−$14.91M
4,313
0.0040%
$481.78K
−25.6%
MAHONEY DAVID L
Director
—
$13.94M (5) scheduled
−$13.94M
1,133,539
1.05%
$126.62M
−8.0%
BELANOFF JOSEPH K
Chief Executive Officer
—
$13.79M (11) scheduled
−$13.79M
2,565,489
2.37%
$286.58M
−5.8%
Vieira Roberto Wandenkolk
President, Oncology
—
$6.46M (7) scheduled
−$6.46M
4,242
0.0039%
$473.85K
+4.3%
WILSON JAMES N
Director
—
$3.94M (12) scheduled
−$3.94M
2,539,086
2.35%
$283.63M
−22.8%
BAKER G LEONARD JR
Director
$3.31M (2)
—
+$3.31M
2,241,893
2.07%
$250.43M
+12.0%
Park Kimberly
Director
—
$3.27M (1) scheduled
−$3.27M
0
0.0000%
$0.00
—
Lyon Joseph Douglas
See Remarks
—
$2.83M (9) scheduled
−$2.83M
5,683
0.0053%
$634.81K
−42.6%
Robb Gary Charles
Chief Business Officer
—
$1.16M (1)
−$1.16M
108,666
0.1005%
$12.14M
+47.2%
Swisher Daniel N JR
Director
—
$192.59K (1) scheduled
−$192.59K
0
0.0000%
$0.00
—
Hunt Hazel
Chief Scientific Officer
—
—
—
255,437
0.2363%
$28.53M
+115.4%
Cannon Gillian
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

76
Insider
Date
Role
Action
Shares
Price
Amount
Lyon Joseph Douglas
14 Sep 2026
See Remarks
Sold after exercise
2,188
$114.12
$249.69K
Lyon Joseph Douglas
14 Sep 2026
See Remarks
Sold after exercise
7,812
$113.32
$885.26K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,225
$115.44
$141.41K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
5,621
$114.58
$644.04K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,606
$113.72
$182.63K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
974
$112.40
$109.47K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
1,537
$111.37
$171.18K
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
23,770
$110.70
$2.63M
Vieira Roberto Wandenkolk
2 Sep 2026
President, Oncology
Sold after exercise
23,600
$109.35
$2.58M
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
2,281
$115.61
$263.71K
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
10,989
$114.71
$1.26M
Maduck Sean
1 Sep 2026
See Remarks
Sold after exercise
11,730
$113.94
$1.34M
Park Kimberly
26 Aug 2026
Director
Sold after exercise
26,685
$122.55
$3.27M
Maduck Sean
25 Aug 2026
See Remarks
Sold after exercise
5,870
$126.06
$739.97K
Maduck Sean
25 Aug 2026
See Remarks
Sold after exercise
25,085
$125.47
$3.15M
Maduck Sean
14 Aug 2026
See Remarks
Sold after exercise
3,664
$114.49
$419.49K
Guyer William
10 Aug 2026
Chief Development Officer
Sold after exercise
4,770
$114.04
$543.96K
Guyer William
10 Aug 2026
Chief Development Officer
Sold after exercise
11,530
$113.18
$1.30M
Maduck Sean
10 Aug 2026
See Remarks
Sold after exercise
1,031
$114.52
$118.07K
Guyer William
4 Aug 2026
Chief Development Officer
Sold after exercise
3,700
$113.12
$418.56K
Maduck Sean
3 Aug 2026
See Remarks
Sold after exercise
20,305
$114.70
$2.33M
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
1,001
$120.67
$120.80K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,103
$119.95
$971.94K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,783
$118.73
$567.91K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,267
$117.93
$974.95K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
7,089
$116.96
$829.10K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
14,222
$115.87
$1.65M
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
15,477
$114.96
$1.78M
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,700
$113.18
$531.94K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
600
$110.95
$66.57K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
2,202
$110.03
$242.28K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
400
$108.46
$43.38K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
8,956
$106.96
$957.89K
Mokari Atabak
30 Jul 2026
Chief Financial Officer
Sold after exercise
4,200
$105.54
$443.25K
Mokari Atabak
15 Jul 2026
Chief Financial Officer
Sold after exercise
101
$89.43
$9.03K
Mokari Atabak
15 Jul 2026
Chief Financial Officer
Sold after exercise
3,520
$88.30
$310.82K
Mokari Atabak
15 Jul 2026
Chief Financial Officer
Sold after exercise
28,460
$87.89
$2.50M
Mokari Atabak
15 Jul 2026
Chief Financial Officer
Sold after exercise
7,919
$86.78
$687.18K
Guyer William
7 Jul 2026
Chief Development Officer
Sold after exercise
952
$93.54
$89.05K
Guyer William
7 Jul 2026
Chief Development Officer
Sold after exercise
19,048
$93.11
$1.77M
Maduck Sean
1 Jul 2026
See Remarks
Sold after exercise
11,175
$89.31
$998.03K
Maduck Sean
1 Jul 2026
See Remarks
Sold after exercise
2,801
$88.51
$247.92K
Maduck Sean
1 Jul 2026
See Remarks
Sold after exercise
11,024
$87.33
$962.78K
Mokari Atabak
15 Jun 2026
Chief Financial Officer
Sold after exercise
2
$82.45
$164.90
Mokari Atabak
15 Jun 2026
Chief Financial Officer
Sold after exercise
19,483
$81.81
$1.59M
Mokari Atabak
15 Jun 2026
Chief Financial Officer
Sold after exercise
11,081
$80.94
$896.92K
Mokari Atabak
15 Jun 2026
Chief Financial Officer
Sold after exercise
9,434
$80.02
$754.92K
Guyer William
2 Jun 2026
Chief Development Officer
Sold after exercise
20,000
$70.60
$1.41M
Mokari Atabak
1 Jun 2026
Chief Financial Officer
Sold after exercise
40,000
$70.00
$2.80M
Maduck Sean
1 Jun 2026
See Remarks
Sold after exercise
3,931
$70.75
$278.10K
Maduck Sean
1 Jun 2026
See Remarks
Sold after exercise
21,069
$70.11
$1.48M
Maduck Sean
27 May 2026
See Remarks
Sold after exercise
20,425
$66.16
$1.35M
Maduck Sean
27 May 2026
See Remarks
Sold after exercise
54,575
$65.37
$3.57M
Guyer William
5 May 2026
Chief Development Officer
Sold after exercise
20,000
$51.83
$1.04M
Guyer William
7 Apr 2026
Chief Development Officer
Sold after exercise
20,000
$40.97
$819.40K
Guyer William
20 Mar 2026
Chief Development Officer
Sold after exercise
11,767
$36.01
$423.73K
Guyer William
4 Mar 2026
Chief Development Officer
Sold after exercise
8,233
$35.99
$296.35K
Guyer William
3 Feb 2026
Chief Development Officer
Sold after exercise
20,000
$40.87
$817.33K
Guyer William
6 Jan 2026
Chief Development Officer
Sold after exercise
20,000
$35.18
$703.66K
Guyer William
2 Dec 2025
Chief Development Officer
Sold after exercise
640
$80.88
$51.76K
Guyer William
2 Dec 2025
Chief Development Officer
Sold after exercise
19,360
$80.05
$1.55M
Lyon Joseph Douglas
1 Dec 2025
See Remarks
Sold after exercise
5,000
$79.53
$397.63K
Maduck Sean
1 Dec 2025
See Remarks
Sold after exercise
20,000
$79.52
$1.59M
Guyer William
5 Nov 2025
Chief Development Officer
Sold after exercise
300
$76.28
$22.88K
Guyer William
5 Nov 2025
Chief Development Officer
Sold after exercise
13,164
$75.64
$995.68K
Guyer William
5 Nov 2025
Chief Development Officer
Sold after exercise
6,536
$74.75
$488.56K
Maduck Sean
3 Nov 2025
See Remarks
Sold after exercise
20,000
$73.99
$1.48M
Lyon Joseph Douglas
3 Nov 2025
See Remarks
Sold after exercise
5,000
$73.65
$368.24K
Swisher Daniel N JR
10 Oct 2025
Director
Sold after exercise
2,200
$87.54
$192.59K
Guyer William
7 Oct 2025
Chief Development Officer
Sold after exercise
20,000
$89.94
$1.80M
Maduck Sean
1 Oct 2025
See Remarks
Sold after exercise
2,647
$85.58
$226.52K
Maduck Sean
1 Oct 2025
See Remarks
Sold after exercise
16,394
$85.06
$1.39M
Maduck Sean
1 Oct 2025
See Remarks
Sold after exercise
959
$83.73
$80.30K
Lyon Joseph Douglas
1 Oct 2025
See Remarks
Sold after exercise
600
$85.39
$51.23K
Lyon Joseph Douglas
1 Oct 2025
See Remarks
Sold after exercise
3,473
$84.92
$294.93K
Lyon Joseph Douglas
1 Oct 2025
See Remarks
Sold after exercise
927
$83.71
$77.60K
Show all 120 transactions →

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 76
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,618,692
History held since 9 Nov 2016